{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-050435","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2025-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.803632+00:00","generated_at":"2026-05-21T01:17:03.076398+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Shareholders approve 2025 Equity Incentive Plan authorizing 3.47M new shares","bullets":["Shareholders voted 20.3M for, 7.1M against to approve the 2025 Equity Incentive Plan.","Plan authorizes 3,474,404 shares for issuance to employees, directors, and consultants.","All eight director nominees elected; say-on-pay and auditor ratification also approved.","Director compensation capped at $750k annually ($1M first year).","Vesting minimum of one year for awards, except up to 5% of shares can have shorter vesting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-050435","json":"https://secwatch.observer/filing/0001104659-25-050435.json","markdown":"https://secwatch.observer/filing/0001104659-25-050435.md","text":"https://secwatch.observer/filing/0001104659-25-050435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465925050435/0001104659-25-050435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465925050435/tm2515549d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T01:17:03.076398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}